Health Catalyst (HCAT) is set to report earnings after market close on Monday. Last quarter, the company met revenue expectations with $80.72 million, up 6.3% year on year. However, full-year revenue guidance missed estimates significantly. Analysts expect a 1.8% revenue decline to $75.01 million this quarter, with adjusted earnings of $0.07 per share. Health Catalyst has a history of meeting or exceeding revenue estimates. Peers like Strategy and Palantir have already reported Q3 results, providing insight into the industry. Health Catalyst is up 6.8% over the last month, with an average analyst price target of $4.33.

Read more at Stockstory.org does not correspond to a specific media company.: Health Catalyst (HCAT) Q3 Earnings: What To Expect